Evidence map›Paper›PMID 28650209›Full record

ReviewExpert review of gastroenterology & hepatology2017

The intestinal barrier: a fundamental role in health and disease.

Maaike Vancamelbeke, Séverine Vermeire

Abstract readReview
In one paragraph

Review in Expert review of gastroenterology & hepatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 678 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
678citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

678 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

618 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Maaike Vancamelbekea Department of Gastroenterology and Translational Research Center for Gastrointestinal Disorders (TaRGID) , University Hospitals Leuven and University of Leuven , Leuven , Belgium.
Séverine Vermeirea Department of Gastroenterology and Translational Research Center for Gastrointestinal Disorders (TaRGID) , University Hospitals Leuven and University of Leuven , Leuven , Belgium.ORCID http://orcid.org/0000-0001-9942-3019

Funding

European Research Council 694679
6 · The paper itself

Abstract

introductionThe gastrointestinal mucosa constitutes a critical barrier where millions of microbes and environmental antigens come in close contact with the host immune system. Intestinal barrier defects have been associated with a broad range of diseases and therefore denote a new therapeutic target. Areas covered: This review is based on an extensive literature search in PubMed of how the intestinal barrier contributes to health and as a trigger for disease. It discusses the anatomy of the intestinal barrier and explains the available methods to evaluate its function. Also reviewed is the importance of diet and lifestyle factors on intestinal barrier function, and three prototypes of chronic diseases (inflammatory bowel disease, celiac disease and nonalcoholic fatty liver disease) that have been linked to barrier defects are discussed. Expert commentary: The intestinal barrier has been investigated by various methods, but correlation of results across studies is difficult, representing a major shortcoming in the field. New upcoming techniques and research on the effect of barrier-restoring therapeutics may improve our current understanding of the gut barrier, and provide a step forward towards personalised medicine.

Indexed as

Celiac DiseaseHumansInflammatory Bowel DiseasesIntestinal MucosaNon-alcoholic Fatty Liver DiseasePermeabilityextraintestinal diseasegut healthintestinal epithelial cellsintestinal inflammationIntestinal mucosal barrierintestinal permeabilitymucus layertight junctions

Identifiers

PMID28650209
PMCPMC6104804

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.